BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kitazawa T, Tsujimoto T, Kawaratani H, Fujimoto M, Fukui H. Expression of Toll-like receptor 4 in various organs in rats with D-galactosamine-induced acute hepatic failure. J Gastroenterol Hepatol. 2008;23:e494-e498. [PMID: 18070011 DOI: 10.1111/j.1440-1746.2007.05246.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Mahmoud MF, Hamdan DI, Wink M, El-Shazly AM. Hepatoprotective effect of limonin, a natural limonoid from the seed of Citrus aurantium var. bigaradia, on D-galactosamine-induced liver injury in rats. Naunyn Schmiedebergs Arch Pharmacol 2014;387:251-61. [PMID: 24258286 DOI: 10.1007/s00210-013-0937-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
2 Dong X, Liu J, Xu Y, Cao H. Role of macrophages in experimental liver injury and repair in mice. Exp Ther Med 2019;17:3835-47. [PMID: 31007731 DOI: 10.3892/etm.2019.7450] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
3 Wang H, Li X, Dong G, Yan F, Zhang J, Shi H, Ning Z, Gao M, Cheng D, Ma Q, Wang C, Zhao M, Dai J, Li C, Li Z, Zhang H, Xiong H. Toll-like Receptor 4 Inhibitor TAK-242 Improves Fulminant Hepatitis by Regulating Accumulation of Myeloid-Derived Suppressor Cell. Inflammation 2021;44:671-81. [PMID: 33083887 DOI: 10.1007/s10753-020-01366-y] [Reference Citation Analysis]
4 Kitazawa T, Tsujimoto T, Kawaratani H, Fukui H. Therapeutic approach to regulate innate immune response by Toll-like receptor 4 antagonist E5564 in rats with D-galactosamine-induced acute severe liver injury. J Gastroenterol Hepatol. 2009;24:1089-1094. [PMID: 19226379 DOI: 10.1111/j.1440-1746.2008.05770.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
5 Jung MG, Do GM, Shin JH, Ham YM, Park SY, Kwon O. Acanthopanax koreanum Nakai modulates the immune response by inhibiting TLR 4-dependent cytokine production in rat model of endotoxic shock. Nutr Res Pract. 2013;7:460-465. [PMID: 24353831 DOI: 10.4162/nrp.2013.7.6.460] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
6 Dong L, Yin L, Quan H, Chu Y, Lu J. Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice. Molecules 2017;22:E1755. [PMID: 29057809 DOI: 10.3390/molecules22101755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
7 Khedr LH, Rahmo RM, Farag DB, Schaalan MF, El Magdoub HM. Crocin attenuates cisplatin-induced hepatotoxicity via TLR4/NF-κBp50 signaling and BAMBI modulation of TGF-β activity: Involvement of miRNA-9 and miRNA-29. Food Chem Toxicol 2020;140:111307. [PMID: 32259551 DOI: 10.1016/j.fct.2020.111307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Osumi W, Jin D, Imai Y, Tashiro K, Li Z, Otsuki Y, Maemura K, Komeda K, Hirokawa F, Hayashi M, Takai S, Uchiyama K. Recombinant human soluble thrombomodulin improved lipopolysaccharide/d-galactosamine-induced acute liver failure in mice. Journal of Pharmacological Sciences 2015;129:233-9. [DOI: 10.1016/j.jphs.2015.11.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
9 Xu YZ, Xue K, Gao Y, Pan MX, Jian GD, Liu XM, Rao JH. Establishment of a non-human primate model of acute liver failure. Shijie Huaren Xiaohua Zazhi 2010; 18(19): 1985-1989 [DOI: 10.11569/wcjd.v18.i19.1985] [Reference Citation Analysis]
10 Kang J, Kim D, Choi JS, Kim YS, Lee S. Scoparone attenuates d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice. Food and Chemical Toxicology 2013;57:132-9. [DOI: 10.1016/j.fct.2013.03.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
11 Mahmoud MF, Gamal S, El-fayoumi HM. Limonin attenuates hepatocellular injury following liver ischemia and reperfusion in rats via toll-like receptor dependent pathway. European Journal of Pharmacology 2014;740:676-82. [DOI: 10.1016/j.ejphar.2014.06.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
12 Guo J, Friedman SL. Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair. 2010;3:21. [PMID: 20964825 DOI: 10.1186/1755-1536-3-21] [Cited by in Crossref: 172] [Cited by in F6Publishing: 164] [Article Influence: 14.3] [Reference Citation Analysis]
13 El-agamy D, Shebl A, Shaaban A. Modulation of d -galactosamine/lipopolysacharride–induced fulminant hepatic failure by nilotinib. Hum Exp Toxicol 2017;37:51-60. [DOI: 10.1177/0960327117689910] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Koo HJ, Lee S, Chang KJ, Sohn E, Sohn EH, Kang SC, Pyo S. Hepatic anti-inflammatory effect of hexane extracts of Dioscorea batatas Decne: Possible suppression of toll-like receptor 4-mediated signaling. Biomed Pharmacother 2017;92:157-67. [PMID: 28538192 DOI: 10.1016/j.biopha.2017.05.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
15 Wang Y, Li Y, Xie J, Zhang Y, Wang J, Sun X, Zhang H. Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. International Immunopharmacology 2013;15:30-7. [DOI: 10.1016/j.intimp.2012.10.026] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 7.6] [Reference Citation Analysis]
16 Duan ZJ, Zhang CL. Progress in developing rat models of hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2010; 18(30): 3204-3209 [DOI: 10.11569/wcjd.v18.i30.3204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Tsujimoto T, Kawaratani H, Kitazawa T, Yoshiji H, Fujimoto M, Uemura M, Fukui H. Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138. World J Gastroenterol 2009; 15(44): 5533-5540 [PMID: 19938191 DOI: 10.3748/wjg.15.5533] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
18 Duan GJ, Zhu J, Xu CY, Wan JY, Zhang L, Ge XD, Liu LM, Liu YS. Protective effect of Gö6976, a PKD inhibitor, on LPS/D: -GalN-induced acute liver injury in mice. Inflamm Res 2011;60:357-66. [PMID: 21063746 DOI: 10.1007/s00011-010-0278-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
19 Fukui H. Cytokines in Hepatic Injury. Liver Pathophysiology. Elsevier; 2017. pp. 341-54. [DOI: 10.1016/b978-0-12-804274-8.00027-8] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Tsujimoto T, Kawaratani H, Kitazawa T, Uemura M, Fukui H. Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis. Dig Dis Sci. 2012;57:1144-1151. [PMID: 22367065 DOI: 10.1007/s10620-012-2073-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
21 Carotti S, Guarino MPL, Vespasiani-Gentilucci U, Morini S. Starring role of toll-like receptor-4 activation in the gut-liver axis. World J Gastrointest Pathophysiol 2015; 6(4): 99-109 [PMID: 26600967 DOI: 10.4291/wjgp.v6.i4.99] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
22 Manzoor S, Khalil S, Malik MA, Shafique K, Gul S, Javed F. Induction of Profibrotic Microenvironment via TLR4 MyD88-Dependent and -Independent Inflammatory Signaling in Chronic Hepatitis C Virus Infection. Viral Immunol 2020;33:585-93. [PMID: 32808884 DOI: 10.1089/vim.2019.0175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Biswas B, Yenugu S. Antimicrobial responses in the male reproductive tract of lipopolysaccharide challenged rats. Am J Reprod Immunol 2011;65:557-68. [PMID: 21199063 DOI: 10.1111/j.1600-0897.2010.00937.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
24 Ben Ari Z, Avlas O, Pappo O, Zilbermints V, Cheporko Y, Bachmetov L, Zemel R, Shainberg A, Sharon E, Grief F. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Cell Physiol Biochem. 2012;29:41-50. [PMID: 22415073 DOI: 10.1159/000337585] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
25 Kitazawa T, Tsujimoto T, Kawaratani H, Fukui H. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats. J Gastroenterol Hepatol. 2010;25:1009-1012. [PMID: 20546456 DOI: 10.1111/j.1440-1746.2009.06145.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]